Similar articles

• So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?

  Warkentin TE, Greinacher A. Warkentin TE, et al. Chest. 2007 Oct;132(4):1108-10. doi: 10.1378/chest.07-1553. Chest. 2007. PMID: 17934108 No abstract available.
• No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis.

  Morris TA, Castrejon S, Devendra G, Gamst AC. Morris TA, et al. Chest. 2007 Oct;132(4):1131-9. doi: 10.1378/chest.06-2518. Epub 2007 Jul 23. Chest. 2007. PMID: 17646239
• The treatment of deep venous thrombosis, including the newer agents.

  Rectenwald JE, Wakefield TW. Rectenwald JE, et al. Dis Mon. 2005 Feb-Mar;51(2-3):104-11. doi: 10.1016/j.disamonth.2005.03.004. Dis Mon. 2005. PMID: 15900261 Review. No abstract available.
• Thromboembolism.

  Fitzmaurice D, Hobbs FD, McManus R. Fitzmaurice D, et al. Clin Evid. 2002 Dec;(8):209-24. Clin Evid. 2002. Update in: Clin Evid. 2003 Dec;(10):273-88. PMID: 12603878 Updated. Review. No abstract available.
• How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?

  Levine RL, McCollum D, Hursting MJ. Levine RL, et al. Chest. 2006 Sep;130(3):681-7. doi: 10.1378/chest.130.3.681. Chest. 2006. PMID: 16963663